Excited to share our new publication in @JCI_insight! We used mass cytometry and machine learning to identify T cell signatures associated with resistance to Chlamydia trachomatis reinfection in women with high exposure.
https://t.co/HgvSjNyMcA
@natstann#Immunology#Chlamydia
Exciting progress in Chlamydia vaccine research! Intranasal immunization with CPAF & ADU-S100 shows promise in reducing infection duration and boosting immune responses in mice. @Els_Vaccine https://t.co/cNasSzejfI
New Research: Systemic priming and intranasal booster with a BcfA-adjuvanted acellular pertussis vaccine generates CD4+ IL-17+ nasal tissue resident T cells and reduces B. pertussis nasal colonization: Introduction
Resurgence of pertussis,… #immunology https://t.co/M1KU3Rvxnp
It’s Giving Tuesday or in UNC speak #TarHealTuesday. @UNC_Micro_Imm is raising funds to support travel of our trainees to scientific conferences. Hoping our successful alumni will lead the way by joining me in supporting this cause and by retweeting! https://t.co/NVyEyv38HE
This new study constitutes a major methodological advance to the study of Chlamydia and furthers our understanding of the bacterial factors contributing to progression through the developmental cycle.
@IsabelleDerre
@@rclaytonbishop
@IsabelleCoppens
https://t.co/NiTR0uJpj7
This new paper from Fullen et al. provides new insights into how B. pertussis has evolved to survive in the mammalian respiratory tract.
Read the full article here: https://t.co/D6rzFcwAo0